Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $1.38B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 102 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $1.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 105 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 106 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 107 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $1.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 109 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $1.16B | Healthcare | Pharmaceuticals | — | Nasdaq |
| 112 | $1.15B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 113 | $1.08B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 114 | $1.05B | Healthcare | Pharmaceuticals | United States | NYSE |
| 115 | $1.04B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 117 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $998.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $983.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 120 | $961.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $943.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 122 | $922.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 123 | $912.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 124 | $902.14M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 125 | $884.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $880.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 127 | $849.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $845.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $835.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 130 | $825.90M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 131 | $820.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $808.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $803.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 134 | $799.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $773.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 136 | $753.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 137 | $736.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $723.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 139 | $717.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $703.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $680.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 142 | $678.29M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 143 | $678.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 144 | $674.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 145 | $671.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 146 | $645.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 147 | $614.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 148 | $596.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $594.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 150 | $586.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 151 | $575.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 152 | $569.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $561.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 154 | $524.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $506.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $506.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 157 | $491.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 158 | $480.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $480.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 160 | $448.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $447.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $443.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $438.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 164 | $420.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 165 | $417.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $411.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 167 | $410.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $404.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $404.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $400.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $396.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $388.44M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 173 | $366.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $356.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 175 | $351.74M | Healthcare | Pharmaceuticals | United States | NYSE |
| 176 | $349.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $329.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 178 | $329.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 179 | $326.81M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 180 | $312.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 181 | $312.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 182 | $305.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $304.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 184 | $302.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 185 | $294.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $290.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 187 | $286.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $285.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 189 | $285.38M | Healthcare | Pharmaceuticals | United States | NYSE |
| 190 | $283.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 191 | $272.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 192 | $258.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 193 | $248.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $247.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $246.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 196 | $242.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $241.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $241.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 199 | $238.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $231.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 409 companies. Market capitalization in USD.